RecruitingNot ApplicableNCT04864080

Transdiagnostic Cognitive Biomarkers


Sponsor

University of Minnesota

Enrollment

45 participants

Start Date

Apr 11, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Arm 1, healthy controls:
  • Have access to the online study platform.
  • Pain or depression

Exclusion Criteria3

  • under 18, non-English speaking
  • Arm 2: pain and depression:
  • pregnant women

Interventions

BEHAVIORALComputer game/task

N-back, COGED, PacMan game, Bandit task, Websurf task.

BEHAVIORALHealth surveys online

Health surveys to study themes like pain, sleep, depression and anxiety, and PTSD.


Locations(1)

University of Minnesota

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04864080


Related Trials